Actively Recruiting
Clinical Trial Recruitment and Retention Strategies for Family Members in the Intensive Care Unit: A Study Within A Trial Randomized Design
Led by Lady Davis Institute · Updated on 2025-06-04
160
Participants Needed
1
Research Sites
35 weeks
Total Duration
On this page
Sponsors
L
Lady Davis Institute
Lead Sponsor
C
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating ways to improve how clinical trials enroll and keep family members of intensive care unit (ICU) patients involved. This study focuses on testing four different strategies—two for recruitment and two for retention—within three ongoing trials involving ICU patient families. The goal is to find better methods to engage families in ICU research, helping to generate stronger evidence to support family engagement practices. The study uses a 2x2 factorial design to randomly assign 160 participants into groups receiving different combinations of recruitment and retention strategies. These include providing a written consent form with a visual infographic to explain key information and offering compensation through e-gift cards for completing enrollment questionnaires. Participants will be enrolled over about six months in three existing ICU family member studies: FAME, VR-Family, and NGAGE. Participants will be monitored for the percentage recruited from those approached and the percentage retained through six months of follow-up after enrollment. Researchers will collect data on enrollment and retention rates to assess which strategies work best. The study involves consenting family members who can communicate in English or French and have a relative expected to stay in the ICU for more than 48 hours. Safety and adherence will be tracked, and the study will conclude by the end of 2026.
CONDITIONS
Brief Title
Clinical Trial Recruitment and Retention Strategies for Family Members in the ICU
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Has family member admitted to an intensive care unit
- Expected hospital stay > 48 hours
- Able to participate in English or French
- Age 18 years or older
You will not qualify if you...
- Has another family member participating in the trial
- Repeat admissions within the study period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - Up to 6 months
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person or remote)
Duration - From enrollment until 6 months follow-up completion
Participants receive recruitment and retention strategies including consent with infographic and/or compensation as part of the study intervention.
Periodic follow-up contacts up to 6 months
Trial Site Locations
Total: 1 location
1
Jewish General Hospital
Montreal, Quebec, Canada
Actively Recruiting
Research Team
J
Jillian Kifell, MSc
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
OTHER
Number of Arms
4
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here